会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Dispensing device, kit containing the device, and method of operating the device
    • 分配装置,包含装置的工具包和操作装置的方法
    • US08469233B2
    • 2013-06-25
    • US12988472
    • 2009-04-16
    • Peter LutzAnnemie Rehor
    • Peter LutzAnnemie Rehor
    • B67B1/00
    • A61M5/31501A61J1/201A61J1/2058A61J1/2096A61M5/19A61M5/284A61M5/3134A61M5/50A61M2005/31506A61M2005/31508
    • The application relates to a dispensing device (1) containing at least one chamber (5, 5′) for receiving a fluid (B, B′), a plunger unit (6) including at least one piston (7, 7′), locking mechanism and counter-locking mechanism as well as a catching mechanism and counter-catching mechanism. The locking mechanism and the counter-locking mechanism can be brought into a locking position (L), in which a movement of the plunger unit (6) in one or both directions is substantially prevented. The catching mechanism and the counter-catching mechanism can be brought into an engagement position (E), in which the locking mechanism and the counter-locking mechanism cannot be brought into the locking position (L). Furthermore, the application relates to a kit (19) containing the dispensing device (1) and to a method of operating the device (1) or kit (19).
    • 本申请涉及一种分配装置(1),其包含用于接收流体(B,B')的至少一个腔室(5,5'),包括至少一个活塞(7,7')的柱塞单元(6) 锁定机构和反锁定机构以及捕捉机构和反捕获机构。 锁定机构和反向锁定机构可以进入锁定位置(L),其中基本上防止了柱塞单元(6)在一个或两个方向上的移动。 捕获机构和反扣机构可以进入接合位置(E),其中锁定机构和反向锁定机构不能进入锁定位置(L)。 此外,本申请涉及包含分配装置(1)的套件(19)和操作装置(1)或套件(19)的方法。
    • 3. 发明授权
    • Polymeric tissue sealant
    • 聚合物组织密封剂
    • US08961947B2
    • 2015-02-24
    • US12102157
    • 2008-04-14
    • Annemie RehorSimona Cerritelli
    • Annemie RehorSimona Cerritelli
    • A61K31/74A61L31/06A61L24/04C08G65/332C08G65/333C08G65/334C08L71/02
    • A61L24/046A61K47/34A61L24/0042A61L31/06A61L2400/04C08G63/00C08G65/3322C08G65/33306C08G65/3342C08G2650/58C08L71/02C08L2666/22
    • Methods for making biomaterials for use as a tissue sealant, kits containing precursors for forming the biomaterials, and the resulting biomaterials are described herein. The biomaterials are formed from a composition comprising at least a first and a second precursor molecule, wherein: i) the first precursor molecule is a poly(ethylene glycol) based polymer having x nucleophilic groups selected from the group consisting of thiol or amino groups, wherein x is greater than or equal to 2 ii) the second precursor molecule is of the general formula: A-[(C3H6O)n—(C2H4O)m—B]i wherein m and n are integers from 1 to 200 i is greater than 2 A is a branch point B is a conjugated unsaturated group The precursors are selected based on the desired properties of the biomaterial. Optionally, the biomaterials contain additives, such as thixotropic agents, radiopaque agents, or bioactive agents. In the preferred embodiment, the biomaterials are used to reduce, inhibit, or contain loss of a biological fluid or gas in a patient.
    • 用于制备用作组织密封剂的生物材料的方法,包含用于形成生物材料的前体的试剂盒以及所得生物材料在本文中描述。 生物材料由包含至少第一和第二前体分子的组合物形成,其中:i)第一前体分子是具有选自硫醇或氨基的x个亲核基团的聚(乙二醇)基聚合物, 其中x大于或等于2 ii)第二前体分子具有以下通式:A - [(C 3 H 6 O)n - (C 2 H 4 O)m -B] i,其中m和n是1至200i的整数更大 优于2 A是分支点B是共轭不饱和基团根据生物材料的所需性质选择前体。 任选地,生物材料含有添加剂,例如触变剂,不透射线剂或生物活性剂。 在优选的实施方案中,生物材料用于减少,抑制或含有患者体内的生物流体或气体的损失。
    • 4. 发明申请
    • POLYMERIC TISSUE SEALANT
    • 聚合组织密封剂
    • US20080253987A1
    • 2008-10-16
    • US12102157
    • 2008-04-14
    • Annemie RehorSimona Cerritelli
    • Annemie RehorSimona Cerritelli
    • A61K31/765C08L71/00A61P41/00
    • A61L24/046A61K47/34A61L24/0042A61L31/06A61L2400/04C08G63/00C08G65/3322C08G65/33306C08G65/3342C08G2650/58C08L71/02C08L2666/22
    • Methods for making biomaterials for use as a tissue sealant, kits containing precursors for forming the biomaterials, and the resulting biomaterials are described herein. The biomaterials are formed from a composition comprising at least a first and a second precursor molecule, wherein: i) the first precursor molecule is a poly(ethylene glycol) based polymer having x nucleophilic groups selected from the group consisting of thiol or amino groups, wherein x is greater than or equal to 2 ii) the second precursor molecule is of the general formula: A-[(C3H6O)n—(C2H4O)m—B]i wherein m and n are integers from 1 to 200 i is greater than 2 A is a branch point B is a conjugated unsaturated group The precursors are selected based on the desired properties of the biomaterial. Optionally, the biomaterials contain additives, such as thixotropic agents, radiopaque agents, or bioactive agents. In the preferred embodiment, the biomaterials are used to reduce, inhibit, or contain loss of a biological fluid or gas in a patient.
    • 用于制备用作组织密封剂的生物材料的方法,包含用于形成生物材料的前体的试剂盒以及所得生物材料在本文中描述。 生物材料由包含至少第一和第二前体分子的组合物形成,其中:i)第一前体分子是具有选自硫醇或氨基的x个亲核基团的聚(乙二醇)基聚合物, 其中x大于或等于2 ii)第二前体分子具有以下通式:<?in-line-formula description =“In-line formula”end =“lead”?> A - [(C